Coronavirus (COVID-19) Q&A
Conversations with frontline clinicians and experts about the COVID-19 pandemic
The Price of Success—How to Evaluate COVID-19 Vaccines When They’re Available Outside of Clinical Trials; When the Human Voice Speaks Volumes About Lung Function; COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
Related Articles:
When the Human Voice Speaks Volumes About Lung Function
COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
Coronavirus trends, variants, vaccines, treatment, and more. JAMA Associate Editor Preeti Malani, MD, MSJ, also from the University of Michigan, and Emory University School of Medicine's Carlos del Rio, MD, return to JAMA's Q&A series to discuss the latest in COVID-19 medicine and public health. Recorded March 15, 2021.
Related Content:
Genetic variants of the SARS-CoV-2 virus are emerging but so far do not seem to have caused breakthrough infections in people with previous infection or in those who have been vaccinated. John P. Moore, PhD, of Weill Medical College of Cornell University in New York, joins JAMA's Q&A series for an update on the latest variants and what you need to know. Recorded March 4, 2021.
Related Article:
Nancy E. Messonnier, MD is director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) and leads the CDC’s efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new Johnson & Johnson vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021.
Related Content:
- Genetic Variants of SARS-CoV-2—What Do They Mean?
- Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD
- SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
- Experts Discuss COVID-19—Vaccine Doses, Virus Variants, and More
- Emergence of a Novel SARS-CoV-2 Variant in Southern California
- SARS-CoV-2 Variants of Concern in the United States
- Pregnant People Getting Mixed Messages About COVID-19 Vaccines
- The Johnson & Johnson Vaccine for COVID-19
- SARS-CoV-2 Viral Variants—Tackling a Moving Target
- Vaccine Distribution—Equity Left Behind?
- Taking Vaccine to Where the Virus Is—Equity and Effectiveness in Coronavirus Vaccinations ?
Interview with James C. Robinson, PhD, author of Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
The CDC coordinated a massive effort to immunize nearly all nursing home and long-term care facility residents in the US against COVID-19 infection in the month after vaccine approval. Ruth Link-Gelles, PhD, MPH, CDC staff epidemiologist and Lieutenant Commander of the US Public Health Service Commissioned Corps, describes how.
Related Article(s):
Researchers Investigate What COVID-19 Does to the Heart; “Important Conversations” Are Needed to Explain the Nocebo Effect; Therapists Donate Their Time to Counsel Distressed Health Care Workers
Related Article:
Researchers Investigate What COVID-19 Does to the Heart
“Important Conversations” Are Needed to Explain the Nocebo Effect
Therapists Donate Their Time to Counsel Distressed Health Care Workers
CDC Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss the agency's response to emerging SARS-CoV-2 variants, implications for the planned vaccine mobilization strategy, the upcoming Johnson & Johnson vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control. Recorded February 17, 2021.
Related Article(s):
Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, including the Johnson & Johnson vaccine, scheduled for a US Food and Drug Administration VRBPAC hearing on February 26, 2021. Recorded February 11, 2021.
Related Article:
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
Natural experiments comparing coronavirus spread on ships and in hair salons with vs without face masks point to the importance of wearing masks for curbing SARS-CoV-2 spread. John T. Brooks, MD, chief medical officer of the CDC’s COVID-19 response team, reviews recently published epidemiologic data that reinforce the role of mask use for pandemic control.
Related Article:
Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2
As US vaccine distribution expands to include younger healthier populations, questions about vaccine safety in women of childbearing age have become more urgent. University of Texas Southwestern Medical Center's Catherine Y. Spong, MD, and Emory University School of Medicine's Denise J. Jamieson, MD, MPH, both eminent obstetrician/gynecologists, join JAMA's Q&A series to discuss the safety of the Pfizer-BioNTech and Moderna vaccines in pregnant and nursing mothers, and in individuals trying to get pregnant. Recorded February 8, 2020.
Related Articles:
Interview with Lawrence O. Gostin, JD, author of Mandating COVID-19 Vaccines
2021 has brought news of emerging SARS-CoV-2 genetic variants that increase transmissibility. Will they diminish vaccine efficacy and lead us to lose pandemic control? University of Michigan's Adam Lauring, MD, PhD, a molecular virologist who uses evolutionary theory to study viral transmission and pathogenesis, joins JAMA's Q&A series to explain the variants and what they mean for public health. Recorded February 4, 2021.
Related Article(s):
NIAID Director Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss
- Shifts in the US pandemic response under the Biden administration
- Emerging genetic variants and implications for vaccine efficacy
- Prospects for new vaccine approvals and more.
Related Article:
Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
Interview with Kristin M. Holland, PhD, MPH, author of Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic
Peter Piot, MD, PhD, director of The London School of Hygiene and Tropical Medicine, is a legend in global health, having been involved in identification of HIV and Ebola virus in Africa. He was founding executive director of UNAIDS and Under Secretary-General of the United Nations from 1995 to 2008. He joins JAMA's Q&A series to discuss the global public health response to COVID-19 past, present, and future. Recorded January 28, 2021.
Related Article(s):
Interview with Donald C. Goff, MD, author of Association of Psychiatric Disorders With Mortality Among Patients With COVID-19
Ethnic and racial minorities have been particularly hard hit with COVID-19 in some communities. Mitchell Katz, MD, president and chief executive officer of New York City Health + Hospitals, and former Los Angeles County health agency director, discusses this problem and what has been learned from COVID-19 that can help resolve the general problem of health care disparities.
Related Article:
Incoming Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss her vision and priorities for the agency and changes in its pandemic response strategies, when she takes the reins on January 20. Recorded January 19, 2021.
Related Article(s):
To get more vaccine to more people more efficiently, UCSF School of Medicine's Robert M. Wachter, MD, recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD, of The Children's Hospital of Philadelphia, disagrees. The two discuss the pros and the cons of the plan and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A series. Recorded January 19, 2021.
Related Article:
Editor in Chief Fred Rivara and Deputy Editor Steve Fihn discuss research published in JAMA Network Open in January 2021
Related Article:
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
Mitchell Katz, MD, president and chief executive officer of New York City Health + Hospitals, and former Los Angeles County health agency director, discusses causes, similarities, and differences between the spike of COVID-19 cases, hospitalizations, and deaths in the 2 cities.
Related Article:
Modernize Medical Licensing, and Credentialing, Too—Lessons From the COVID-19 Pandemic
The COVID-19 pandemic has prompted scientists to use adaptive research designs to evaluate potential treatments simultaneously and efficiently, increasing the likelihood that patients will receive treatments most likely to be effective for them. Lennie Derde, MD, of University Medical Center Utrecht in the Netherlands and JAMA Associate Editor Christopher W. Seymour, MD, of University of Pittsburgh Medical Center join JAMA's Q&A series to discuss the latest in critical care management of COVID-19 patients and emerging treatment strategies and therapies. Recorded January 13, 2021.
Related Article(s):
Sensible Medicine-Optimizing the Trade-off Between Learning and Doing in a Pandemic
Arnold S. Monto, MD, chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EUA) of the Pfizer/BioNTech and Moderna vaccines. He joins JAMA's Q&A series from the University of Michigan School of Public Health to discuss experience to date with the 2 products and what's next in vaccine development. Recorded January 11, 2021.
Related Article(s):
Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More
Interview with Samyukta Mullangi, MD, MBA, author of The COVID-19 Pandemic—An Opportune Time to Update Medical Licensing; also with Mitchell H. Katz, MD, chief executive officer of New York City Health and Hospitals and author of Modernize Medical Licensing, and Credentialing, Too—Lessons From the COVID-19 Pandemic
Aaloke Mody, MD, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study that uses Lorenz curves as a metric for quantifying racial inequities in coronavirus disease 2019 (COVID-19) testing. Read the article here: https://ja.ma/2MOMjWG.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Gregory Armstrong, MD, director of the Advanced Molecular Detection Program for the CDC, explains what is currently known about the new mutations of SARS-CoV-2.
Related Article(s):
Tom Shimabukuro, MD, MPH, MBA, and Sara Mbaeyi, MD, MPH, from the CDC discuss rare allergic complications in patients who received the first dose of the Pfizer-BioNTech vaccine between December 14-23, 2020.
Adam Lauring, MD, PhD, from the University of Michigan Division of Infectious Diseases, an expert on the evolutionary biology of RNA viruses, explains the new genetic variants recently found in SARS-CoV-2 and their importance.
Related Article(s):
Genetic Variants of SARS-CoV-2—What Do They Mean?
Nicole Kravitz-Wirtz, PhD, MPH, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study describing individuals’ concerns regarding violence in the context of the coronavirus disease 2019 (COVID-19) pandemic, experiences of pandemic-related unfair treatment, prevalence of and reasons for firearm acquisition, and changes in firearm storage practices due to the pandemic. Read the article here: https://ja.ma/2X7lC1x.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Elderly persons and residents of nursing homes have been the hardest hit in the COVID-19 pandemic. Harvard geriatrician Sharon Inouye, MD, discusses the effect COVID-19 has had on nursing homes and what should be done about it.
Related Article:
Communication science expert Brian Southwell, PhD, recently launched a training workshop at the Duke University School of Medicine to address a major clinical problem: What should physicians do when patients are misinformed about their health? It’s one of only a few such programs in the nation. Southwell, a scholar with the medical school’s Social Science Research Institute and a senior director at the independent, nonprofit research institute RTI International, chatted with JAMA Medical News Associate Managing Editor Jennifer Abbasi about the viral spread of false health information and malicious disinformation campaigns, why we’re vulnerable to falling for them, and how time-pressed physicians can deal with all the noise.
Related Article(s):
COVID-19 Conspiracies and Beyond: How Physicians Can Deal With Patients’ Misinformation
Emily A. Largent, JD, PhD, RN, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study assessing the acceptability of coronavirus disease 2019 (COVID-19) vaccine mandates among members of the US public. Read the article here: https://ja.ma/3nGKAQP.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020.
Related Article:
The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials
Peter W. Marks, MD, PhD, and Stephen M. Hahn, MD, return to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the data, the weekend's EUA designation (Pfizer/BioNTech), and the process for future full licensure and postmarketing safety surveillance.
Dr Marks directs the US FDA's Center for Biologics Evaluation and Research (CBER).
Dr Hahn is commissioner of the US Food and Drug Administration.
Recorded December 14, 2020.
Related Article(s):
Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program
Ala Stanford, MD, founder of Philadelphia’s Black Doctors COVID-19 Consortium, talks with JAMA Medical News Staff Writer Mary Chris Jaklevic about her work to establish COVID-19 testing sites for the city’s Black residents.
Related Article:
Surgeon Fills COVID-19 Testing Gap in Philadelphia’s Black Neighborhoods
JAMA Fishbein Fellow Kristin Walter, MD, interviews Craig Garfield, MD, and Richard Weissbourd, EdD, about parental relationships during the COVID-19 pandemic.
Related Article:
Considerations for Young Children and Those With Special Needs as COVID-19 Continues
Hannah Wunsch, MD, MSc, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cohort study comparing the New York State Ventilator Allocation Guideline with the original triage criteria proposed by White and Lo to determine which and how many admissions to US intensive care units are identified as having the lowest priority for ventilator allocation. Read the article here: https://ja.ma/37k0sTE.
Watch the JAMA Coronavirus Q&A with Douglas B. White, MD, MAS from March 27, 2020: https://edhub.ama-assn.org/jn-learning/video-player/18365657
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the public data, deliberations at Thursday's FDA Advisory Committee meeting, and prospects for an agency Emergency Use Authorization designation, licensure, and rollout. Recorded December 11, 2020.
Related Article(s):
The COVID Tracking Project, launched by The Atlantic, collects and publishes data required to understand the COVID-19 outbreak in the US, including data on race and ethnicity needed to understand health inequities in the outbreak. Atlantic Monthly journalists Alexis C. Madrigal and Erin Kissane join JAMA's Q&A series to describe the project and their experience developing a database for fact-based health reporting on the pandemic. Recorded December 10, 2020.
Lockdowns resulting from COVID-19 have had a devastating effect on everyone’s personal lives and the economy. What factors in people’s daily lives are most associated with SARS-CoV-2 transmission between people? Manish Patel, MD, team lead of the CDC’s Influenza Prevention & Control Team, discusses a study they conducted examining what sorts of activities might be associated with COVID-19 disease transmission.
Related Article(s):
Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China
Ellen H. Lee, MD, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cohort study describing the distribution of race/ethnicity among cases of coronavirus disease 2019 (COVID-19)–associated multisystem inflammatory syndrome in children reported to the New York City Department of Health and Mental Hygiene. Read the article here: https://ja.ma/37vCJ1K.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open.
Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Closing businesses during the COVID-19 pandemic has had devastating consequences for individuals and the economy in general. Proper air handling combined with the use of masks and physical distancing can greatly improve the safety of indoor spaces. Joseph Allen, DSc, MPH, assistant professor of exposure assessment science at Harvard T.H. Chan School of Public Health, and Andrew Ibrahim, MD, assistant professor of surgery and architecture and urban planning at the University of Michigan, discuss air conditioning standards that can substantially reduce the risk of disease transmission in indoor spaces.
Related Article(s):
With the Pfizer and Moderna coronavirus vaccines reportedly under review at the US FDA for Emergency Use Authorization (EUA), Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on what to expect, prospects for vaccine rollout and distribution in the coming months, and ongoing safety surveillance. Recorded December 2, 2020.
Related Article:
Yale Sterling Professor Nicholas A. Christakis, MD, PhD, returns to JAMA's Q&A series to discuss the surge in US cases and other recent pandemic developments. Dr Christakis is author of the recently published book "Apollo's Arrow: The Profound and Enduring Impact of Coronavirus on the Way We Live." Recorded November 23, 2020.
Maura Kennedy, MD, MPH, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cohort study examining how frequently older adults with coronavirus disease 2019 (COVID-19) present to the emergency department with delirium and their associated hospital outcomes. Read the article here: https://ja.ma/3q5h74S.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
In the midst of rising COVID-19 case rates globally, Derek C. Angus, MD, MPH, and Rochelle P. Walensky, MD, MPH, return to JAMA's Q&A series to update viewers on developments in the pandemic and the critical care management of COVID-19 patients. Dr Angus is Chief Health Care Innovation Officer at the University of Pittsburgh Medical Center, professor and chair of Critical Care Medicine, and a senior JAMA editor. Dr Walensky is Chief of Infectious Diseases at Massachusetts General Hospital and a professor at Harvard Medical School. Recorded November 19, 2020.
Related Article(s):
Optimizing the Trade-off Between Learning and Doing in a Pandemic
Interview with Ipsit V. Vahia, MD, author of Older Adults and the Mental Health Effects of COVID-19
Related Article(s):
Would letting coronavirus infect the broad US and global population be a safe and effective means of ending the COVID-19 pandemic? Jay Bhattacharya, MD, PhD, of Stanford University's Center for Primary Care and Outcomes Research is a signatory of the "Great Barrington Declaration," which proposes to "allow those at minimal risk of death to live their lives normally to build up immunity to the virus through natural infection, while better protecting those who are at highest risk." Marc Lipsitch, PhD, of the Harvard T.H. Chan School of Public Health, a signatory of the "John Snow Memorandum," which refutes the argument, responds.
Related Article:
Ngozi O. Ezike, MD, director of the Illinois Department of Public Health, discusses state and regional management of the COVID-19 pandemic. Recorded November 9, 2020.
Related Article(s):
Catherine R. Butler, MD, MA joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a qualitative study describing the perspectives and experiences of clinicians involved in institutional planning for resource limitation and/or patient care during the coronavirus disease 2019 (COVID-19) pandemic.
Read the article here: https://ja.ma/32vBC0h.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Roy H. Perlis, MD, MSc, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cohort study assessing admission laboratory and comorbidity features associated with critical illness and mortality risk among patients hospitalized with coronavirus disease 2019 (COVID-19) across 6 Eastern Massachusetts hospitals.
Read the article here: https://ja.ma/384dBkt. JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open.
Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Interview with Carlos del Rio, MD, author of Long-term Health Consequences of COVID-19
Related Article:
JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor in Chief of JAMA Network Open for the November 2, 2020 issue.
Tim Uyeki, MD, chief medical officer for the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), discusses how the COVID-19 pandemic may affect the 2020-2021 influenza season.
Related Article:
Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic, including the continued importance of nonpharmaceutical interventions (masking, handwashing, physical distancing) for managing rising case numbers in the US and globally. Recorded October 28, 2020.
Related Article(s):
Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on progress in COVID-19 vaccine development. Recorded October 27, 2020.
Related Article(s):
Large Meta-analysis Digs Into Obesity’s COVID-19 Risks; As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts; Telephone Visits Surge During the Pandemic, but Will They Last?
Related articles:
Large Meta-analysis Digs Into Obesity’s COVID-19 Risks
As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts
Telephone Visits Surge During the Pandemic, but Will They Last?
John S. Brownstein, PhD and Douglas L. Kriner, PhD join JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study evaluating the factors associated with US adults’ choice of and willingness to accept a hypothetical COVID-19 vaccine.
Read the article here: https://ja.ma/3e0Rz3i.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Interview with Aaron L. Baggish, MD, and Jonathan H Kim, MD, authors of Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play, and James E. Udelson, MD, author of Return to Play for Athletes After Coronavirus Disease 2019 Infection—Making High-Stakes Recommendations as Data Evolve
Rochelle P. Walensky, MD, MPH, of Harvard Medical School and Massachusetts General Hospital returns to JAMA's COVID-19 Q&A to provide an update on developments in the pandemic. She is a signatory of the recent John Snow Memorandum emphasizing the importance of public health interventions to manage the spread of COVID-19. Recorded October 22, 2020.
Related Article(s):
Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
The costs of the coronavirus pandemic are unprecedented in their dimensions: David M. Cutler, PhD, of Harvard University discusses financial costs: the $16 trillion virus.
Lisa Cooper, MD, MPH, of Johns Hopkins University discusses the costs to communities of color in excess deaths and bereavement.
Charles R. Marmar, MD, of NYU Grossman School of Medicine discusses the mental health costs. Recorded October 20, 2020.
Related Article(s):
Andy Slavitt, MBA, discusses recent developments in the COVID-19 pandemic and the US response. Slavitt is former Acting CMS Administrator in the Obama administration, board director at the United States of Care in Washington, DC, and a Distinguished Health Policy Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania in Philadelphia. Recorded October 16, 2020.
Related Article:
Many people are hoping that enough people develop resistance to COVID-19, either from being exposed to the disease or from vaccination, to develop herd immunity that will enable society to return to normal. But will that happen? Saad Omer, MD, from the Yale Institute for Global Health, discusses his JAMA article on herd immunity and how much we can count on having it to return society to normal from this COVID-19 pandemic.
Related Article(s):
The National Academy of Medicine has recommended that racial minority populations receive priority for vaccination because they have been hard hit by the pandemic and are "worse off" socioeconomically. US law is inconsistent on whether race/ethnicity can be an explicit criterion for achieving equity and diversity. Lawrence O. Gostin, JD, of Georgetown University and Michelle A. Williams, ScD, of Harvard T.H. Chan School of Public Health discuss ways to achieve the public health objective of protecting vulnerable communities while adhering to law and ethics. Recorded October 14, 2020.
Related Article(s):
Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
University of North Carolina (UNC) at Chapel Hill nutrition scholar Barry Popkin, PhD, and JAMA Medical News Associate Managing Editor Jennifer Abbasi discuss new findings on obesity and COVID-19. Popkin is the lead author of a systematic review and meta-analysis on the topic that was published recently in Obesity Reviews. He is a distinguished professor in the department of nutrition at the UNC Gillings School of Global Public Health.
Related Article(s):
Interview with Christopher W. Seymour, MD, MSc, author of Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic
Related Article(s):
Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic
On October 2 the US National Academies of Science, Engineering, and Medicine issued its consensus Framework for Equitable Allocation of a COVID-19 Vaccine. William H. Foege, MD, MPH, emeritus distinguished professor of International Health at the Rollins School of Public Health at Emory University, cochaired the committee that authored the report and discusses its recommendations. Recorded October 2, 2020.
Peter Marks, MD, PhD, directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn. He joins JAMA Editor Howard Bauchner, MD, for an update on vaccine progress to date and prospects for pre-election political interference in the FDA approval process. Recorded October 5, 2020.
Related Article(s):
Sarah E. Gollust, PhD joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study examining public perception of high priority groups for receipt of an eventual coronavirus disease 2019 vaccine in case of shortage of supply. Read the article here: https://ja.ma/3d2101T.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Sweden’s response to the COVID-19 pandemic differed from its neighbors in Europe. Lockdowns were minimized with the belief that they would be more damaging than the virus itself. Much criticism was levied at the country regarding these policies. Anders Tegnell, MD, is the head of the Department of Public Health Analysis and Data Management, Deputy Director General at the Public Health Agency of Sweden, and had been Sweden's state epidemiologist since 2013. He discusses what Sweden did in response to COVID-19 and what their outcomes were.
Related Article:
H. Nina Kim, MD, MSc and Herbert C. Duber, MD, MPH join JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study evaluating the proportion of patients tested for coronavirus disease 2019 (COVID-19) and the proportion of positive cases, using language as a surrogate for immigrant status. Read the article here: https://ja.ma/3d2101T.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020.
Related Article(s):
Michael T. Osterholm, PhD, MPH, returns to JAMA's Coronavirus Q&A series to discuss the latest developments in the COVID-19 pandemic. He is director of the Center for Infectious Disease Research and Policy (CIDRAP) at University of Minnesota and a veteran of pandemic planning. Recorded September 23, 2020.
Related Article(s):
Hydroxychloroquine and convalescent plasma approvals by the FDA under Emergency Use Authorization (EUA) protocols have raised concerns the agency is under withering political pressure to fast-track a COVID-19 vaccine before it is proven safe and effective. Joshua Sharfstein, MD, Johns Hopkins Bloomberg School of Public Health, and JAMA Associate Editor Preeti Malani, MD, University of Michigan, discuss implications for public health and policy responses to ensure vaccine safety. Recorded September 18, 2020.
Related Article:
What Happens When COVID-19 Collides With Flu Season?; Flu Vaccination Urged During COVID-19 Pandemic; COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Related Article(s):
What Happens When COVID-19 Collides With Flu Season?
Flu Vaccination Urged During COVID-19 Pandemic
COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Science communications expert Dominique Brossard, PhD, and JAMA Medical News Associate Managing Editor Jennifer Abbasi discuss research-based strategies to encourage mask wearing, social distancing, and hand washing during the COVID-19 pandemic. Dr. Brossard is a professor and chair of the Department of Life Sciences Communication at the University of Wisconsin-Madison and part of a new COVID-19-focused National Academies of Science, Engineering, and Medicine group.
Related Article(s):
The Science of Persuasion Offers Lessons for COVID-19 Prevention
Song Gao, PhD and Ajay K. Sethi, PhD join JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study using anonymous location data from 45 million mobile phones to determine if stay-at home orders were associated with decreased median travel distance and slower #COVID19 spread.
Read the article here: https://ja.ma/2ZCqm0A.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Interview with Aaron S. Kesselheim, MD, author of Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency
Related Article(s):
Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency
New data show unfavorable US trends in hypertension and obesity, with communities of color doing worse. National Institute of Diabetes and Digestive and Kidney Diseases Director Griffin P. Rodgers, MD, and National Heart, Lung, and Blood Institute Director Gary H. Gibbons, MD, discuss the implications for COVID-19 outcomes and public health. Recorded September 10, 2020.
Related Article(s):
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor in Chief of JAMA Network Open for the September 8, 2020 issue.
David O. Meltzer, MD, PhD, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cohort study examining whether patients’ most recent vitamin D levels and treatment for insufficient vitamin D levels are associated with test results for coronavirus disease 2019 (COVID-19).
Read the article here: https://ja.ma/2ZkvGpf.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020.
Related Article(s):
COVID-19 continues to rapidly spread throughout the world. In the past few months, the population affected by the disease has shifted from older to younger patients. Public health officials are concerned that younger people seem not to be very compliant with recommendations regarding masking and social distancing. It is believed that younger people think that the adverse consequences of the disease occur in the elderly and not in them. Garret Salzman, MD, is a resident physician at UCLA and contracted the disease. He is young and healthy, but he has had substantial disability from COVID-19. He tells a cautionary tale of his experience with COVID-19 that this is not a benign disease in young people, that they need to be careful.
Related Article:
Potential Implications of COVID-19 for the 2020-2021 Residency Application Cycle
Paul A. Offit, MD, of the Children's Hospital of Philadelphia provides an update on COVID-19 vaccine development. Recorded August 24, 2020.
Related Article:
Alyssa Bilinski, MS, and Joshua A. Salomon, PhD, join JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a mathematical modeling study examining the potential for contract tracing to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the context of reduced physical distancing under different assumptions for case detection, tracing, and quarantine efficacy. Read the article here: https://ja.ma/3ixDJ9j
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open.
Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
CDC Director Robert Redfield, MD, discusses recent developments in the COVID-19 pandemic and US response, including prospects for dual outbreaks of COVID-19 and influenza in the fall and winter.
Related Article(s):
Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic
Ezekiel Emanuel, MD, PhD, of the University of Pennsylvania's Perelman School of Medicine, Department of Medical Ethics and Health Policy, discusses recent developments in the COVID-19 pandemic. Recorded August 19, 2020.
Related Article(s):
The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”)
As the COVID-19 pandemic continues to spread throughout the world, flu season is almost upon us. This is concerning because there will be an overlap between flu and COVID-19 and patients could get both diseases. Daniel Solomon, MD, from the Division of Infectious Diseases at the Brigham and Women’s Hospital of the Harvard Medical School in Boston, discusses COVID-19 and how the flu might pan out this year.
Related Article:
Before COVID-19, even though most children got vaccinated for measles, too many did not, resulting in worsening outbreaks of measles. People forgot how bad a disease measles is and became lax about getting their children vaccinated. Now in the COVID-19 era everyone is aware of what an out-of-control infectious disease can do and we are all anxiously awaiting a COVID-19 vaccine. Will this experience help encourage parents to get their children vaccinated? We discussed the problems of an adequate measles vaccination with Dr. Saad Omer, PhD, from the Yale Institute for Global Health at Yale University in New Haven, Connecticut.
Related Article(s):
The use of hydroxychloroquine as a treatment for COVID-19 serves as an example of what is wrong with medical information being widely disseminated before it is thoroughly vetted by peer review. Preliminary studies of this treatment modality were spread widely, creating false hope that a treatment for COVID-19 existed. Several randomized trials have shown that hydroxychloroquine is not an effective therapy for COVID-19.
David Juurlink, MD, PhD, from the University of Toronto summarizes the evidence base regarding hydroxychloroquine and COVID-19.
Related Article(s):
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
One of the most contentious issues relating to COVID-19 is when to reopen schools. This is a complicated matter because placing people in close quarters risks spread of the disease. Yet children being at home makes it difficult for their working parents to manage their affairs and can potentially affect the learning experience. JAMA Associate Editor Preeti Malani, MD, chief health officer for the University of Michigan, discusses school reopening and how the University of Michigan is addressing this problem.
Related Article:
Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US
Harvey W. Kaufman, MD joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study examining changes in the number of patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic in the United States.
Read the article here: https://ja.ma/31khw7X.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Soumya Swaminathan, MD, DNB, chief scientist at the World Health Organization (WHO), discusses the global coronavirus pandemic and the WHO response. Recorded August 5, 2020.
Related Article:
COVID-19 Reveals Urgent Need to Strengthen the World Health Organization
Anthony Fauci, MD, White House Coronavirus Task Force member and director of the National Institute of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded August 3, 2020.
Related Article(s):
Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism
Few treatments have proven to be effective for treating COVID-19. Recently, a clinical trial reporting the results of dexamethasone for treating COVID-19 was published and has received a great deal of attention in the popular media. Greg Curfman, MD, JAMA Deputy Editor, reviews the study and discusses what the findings do or do not reveal about the efficacy of dexamethasone for treating COVID-19.
Related Article(s):
Roberta L. Schwartz, PhD joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study examining rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among asymptomatic health care workers and community residents in the greater Houston, Texas, area.
Read the article here: https://ja.ma/3f8lvcz.
JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Interview with Madeline R. Sterling, MD, author of Experiences of Home Health Care Workers in New York City During the Coronavirus Disease 2019 Pandemic: A Qualitative Analysis, and Theresa A. Allison, MD, PhD, author of Extreme Vulnerability of Home Care Workers During the COVID-19 Pandemic—A Call to Action
US Food and Drug Administration (FDA) Commissioner Stephen Hahn, MD, discusses the agency's role in responding to the COVID-19 pandemic. Recorded July 30, 2020.
Related Article:
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
